Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 19.04B P/E 19.31 EPS this Y 9.30% Ern Qtrly Grth -
Income 379.2M Forward P/E 14.37 EPS next Y 8.20% 50D Avg Chg 6.00%
Sales 12.16B PEG 1.63 EPS past 5Y 8.18% 200D Avg Chg 7.00%
Dividend 1.00% Price/Book 2.17 EPS next 5Y 8.36% 52W High Chg -5.00%
Recommedations 2.00 Quick Ratio 0.82 Shares Outstanding 84.13M 52W Low Chg 25.00%
Insider Own 0.34% ROA 3.77% Shares Float 83.67M Beta 1.00
Inst Own 98.27% ROE 4.23% Shares Shorted/Prior 1.92M/2.13M Price 214.94
Gross Margin 27.67% Profit Margin 3.44% Avg. Volume 738,014 Target Price 246.13
Oper. Margin 7.20% Earnings Date Apr 25 Volume 625,928 Change 0.62%
About Laboratory Corporation of Ameri

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Laboratory Corporation of Ameri News
04/16/24 Labcorp (LH) to Report Q1 Earnings: What's in the Cards?
04/15/24 Laboratory Corporation of America Holdings (NYSE:LH) Has Announced A Dividend Of $0.72
04/15/24 Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
04/12/24 Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod
04/11/24 Myriad Genetics (MYGN) Announces Favorable Research Results
04/11/24 Labcorp Declares Quarterly Dividend
04/10/24 Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
04/09/24 Labcorp's (LH) Strategic Alliances Aid Amid Macroeconomic Woes
04/08/24 Labcorp (LH) Extends MRD Clinical Research With New Launch
04/08/24 Do You Think Laboratory Corporation of America Holdings (LH) Valuation is Not Attractive Anymore?
04/08/24 Here’s Why Vltava Fund Sold Lockheed Martin Corporation (LMT)
04/08/24 Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
04/05/24 Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
04/03/24 Insider Sell: EVP, President Diagnostics & COO Mark Schroeder Sells Shares of Laboratory ...
04/03/24 Insider Sell: EVP, Chief Marketing Officer Amy Summy Sells 3,500 Shares of Laboratory Corp of ...
04/02/24 Here's Why Investors Should Retain Labcorp (LH) Stock for Now
04/02/24 Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research
04/01/24 OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
04/01/24 Labcorp (LH) to Boost Clinical Diagnostics With New Deal
04/01/24 Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
LH Chatroom

User Image Stock_Titan Posted - 2 days ago

$LH Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw https://www.stocktitan.net/news/LH/labcorp-announces-first-of-its-kind-test-for-early-indication-of-9tsy182hil5l.html

User Image DonCorleone77 Posted - 1 week ago

$LH Labcorp receives FDA EUA for Mpox PCR Test Home Collection Kit Labcorp announced today the FDA has granted Emergency Use Authorization, or EUA, for its Mpox PCR Test Home Collection Kit to aid in the diagnosis of infection with non-variola Orthopoxvirus, including the monkeypox virus that causes monkeypox, also known as mpox. The test is the first mpox at-home collection kit authorized by FDA and is available to physicians to order for patients 18 years of age or older who are suspected of mpox infection.

User Image Stock_Titan Posted - 1 week ago

$LH Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit https://www.stocktitan.net/news/LH/labcorp-receives-fda-emergency-use-authorization-for-mpox-pcr-test-cer3xs0fs8ps.html

User Image Stock_Titan Posted - 1 week ago

$LH Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs https://www.stocktitan.net/news/LH/labcorp-announces-expansion-of-precision-oncology-portfolio-to-p9k7d5sbb67i.html

User Image Stock_Titan Posted - 1 week ago

$LH Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research https://www.stocktitan.net/news/LH/labcorp-launches-labcorp-r-plasma-detect-extending-leadership-into-mtaeekl3kfrp.html

User Image insiderbuyingselling Posted - 2 weeks ago

$LH new insider selling: 3500 shares. http://insiderbuyingselling.com/?t=LH

User Image DC729 Posted - 2 weeks ago

@ExNoose @Wax_Bean_futures $LH should acquire $PSNL

User Image Stock_Titan Posted - 2 weeks ago

$LH Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research https://www.stocktitan.net/news/LH/labcorp-to-present-diverse-portfolio-of-precision-oncology-research-x1nrpo1td0dr.html

User Image Stock_Titan Posted - 2 weeks ago

$LH Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp https://www.stocktitan.net/news/LH/xcell-biosciences-strengthens-cell-and-gene-therapy-collaboration-bc56c1iufzxp.html

User Image insiderbuyingselling Posted - 03/29/24

$LH new insider selling: 3553 shares. http://insiderbuyingselling.com/?t=LH

User Image Stock_Titan Posted - 03/29/24

$LH The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab https://www.stocktitan.net/news/LH/the-prelude-network-r-names-labcorp-its-preferred-genetic-carrier-lbnd4r6n5me6.html

User Image OpenOutcrier Posted - 03/28/24

$OPK (+5.6% pre) $LH Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. - SI https://ooc.bz/l/28972

User Image DonCorleone77 Posted - 03/28/24

$LH $OPK Labcorp to acquire select assets of BioReference Health for $237.5M Labcorp (LH) and OPKO Health (OPK) announce that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. Through this transaction, Labcorp will acquire BioReference Health's laboratory testing businesses focused on clinical diagnostics and reproductive and women's health across the United States outside of New York and New Jersey. This transaction includes patient service centers and certain customer contracts and operating assets. BioReference Health will continue to offer oncology and urology diagnostic services nationwide, as well as maintain its full operations in New York and New Jersey. When complete, the transaction is expected to provide patients, physicians and customers with greater access to Labcorp's comprehensive, high-quality laboratory services, scientific expertise and expanded testing capabilities....

User Image Stock_Titan Posted - 03/28/24

$OPK $LH Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business https://www.stocktitan.net/news/OPK/labcorp-announces-acquisition-of-select-assets-of-bio-reference-k4ix9p5fuxi9.html

User Image Stock_Titan Posted - 03/27/24

$LH Labcorp to Announce First Quarter Financial Results on April 25, 2024 https://www.stocktitan.net/news/LH/labcorp-to-announce-first-quarter-financial-results-on-april-25-d1xovi8l02qr.html

User Image Stock_Titan Posted - 03/20/24

$LH Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials https://www.stocktitan.net/news/LH/labcorp-launches-p-tau217-blood-biomarker-test-to-accelerate-path-to-ouk39ybe84dx.html

User Image EmmaRespond Posted - 03/20/24

Laboratory Corporation of America Holdings: A Promising Investment Opportunity to Consider $LH http://dlvr.it/T4L7zW

User Image EmmaRespond Posted - 03/20/24

Laboratory Corporation of America Holdings: A Promising Investment Opportunity to Consider $LH http://dlvr.it/T4L6SK

User Image Chark Posted - 03/18/24

$LH Ahhhh, a gap on the 180 at 204.89 that I didn't see before. Going to fill that first. Great entry after the fill. That is why you look at all time frames. Apologies.

User Image tradingtwenty Posted - 1 month ago

$LH has trended 47 times in the past 24 hours (based on 5 minute intervals). Latest article on Mar 16, 2024 10:29 AM: Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted... Link: https://tradingtwenty.com/news/396214/labcorp-presents-new-research-demonstrating-clinical-impact-of-precision-diagnostics-in-guiding-biomarker-targeted-therapies-for-patients-with-epithelial-ovarian-cancer

User Image Chark Posted - 1 month ago

$LH The Primary Elliott wave has not yet begun an Impulse wave on the daily but it has on the 180 so this will be off to the races imminently & this is where you want to catch the Impulse B wave, which can be quite long & strong. LRC is still in a strong uptrend. Great entry soon.

User Image Chark Posted - 1 month ago

$LH This is the daily sequence counter, Elliott fractals, Darvas Box, & trendlines. The Darvas Box still has a sell signal, the sequence is only on a 4 & it will pop at 9, so it could breach that trendline, hit strong support & bounce, so give this entry a little latitude. As you can see the indicators are already beginning to turn up. Watch for the set ups people. Trade the charts. Math works.

User Image Chark Posted - 1 month ago

$LH This is the 5yr daily for clarity. It is right at the bottom of the trendline in a bullish harami, nearing oversold, & ready to pop. It could see a couple of points lower but not many, unless it breaches the trendline. I think it holds.

User Image Chark Posted - 1 month ago

$LH This is the LT chart & this is why you begin at the larger time frames. The Weinstein pattern is almost complete & it will begin a base imminently. The pattern is right at the pivotal "do or die" place of strong support, & all indicators are pointing to a reversal off of the bottom trendline. Great entry if it holds that line. All indicators still falling but not for long.

User Image InsiderPeek Posted - 1 month ago

$LH Chief Marketing Officer Summy Amy B. sold 227 shares for $49.6k (ownership down 5.56%) insiderpeek.com/company/LH

User Image briefingcom Posted - 1 month ago

$FTRE: Fortrea (-2.1%), which was spun off from LabCorp $LH in July 2023, is heading lower after the contract research organization (CRO) reported a Q4 miss for both EPS and revenue. The company also announced it will divest its Enabling Services segment called Endpoint Clinical and its Fortrea Patient Access unit to private equity firm Arsenal Capital Partners, which specializes in building technology-rich healthcare companies. The deal is expected to close in Q2. Fortrea has reported two earnings reports as an independent company. This Q4 miss was a bit of a surprise following the company's solid upside in Q3. Despite the miss, Fortrea noted that it was pleased with its book-to-bill ratio for Q4 at 1.3x, bringing it to a book-to-bill of more than 1.27x for its first six months as an independent organization. https://www.briefing.com/story-stocks/archive/2024/3/11/fortrea-heads-lower-on-earnings-miss-also-announced-sale-to-focus-on-being-a-pureplay-cro-(ftre)?utm_campaign=storystocks&utm_medium=social&utm_source=st&utm_content=link

User Image insiderbuyingselling Posted - 1 month ago

$LH new insider selling: 5048 shares. http://insiderbuyingselling.com/?t=LH

User Image Stock_Titan Posted - 1 month ago

$LH Labcorp Launches Weight Loss Management Testing Solutions https://www.stocktitan.net/news/LH/labcorp-launches-weight-loss-management-testing-vrjg0j0bnsay.html

User Image Stock_Titan Posted - 1 month ago

$LH PINNACLE FERTILITY PARTNERS WITH LABCORP TO ENHANCE GENETIC TESTING SERVICES https://www.stocktitan.net/news/LH/pinnacle-fertility-partners-with-labcorp-to-enhance-genetic-testing-8lqwxhghlnqi.html

User Image TickerDD_com Posted - 02/26/24

From 2/16/2024, looking back across 22 Month-Ends for LH, Percentage Change of Average Monthly Price had More Negatives (59%) while Percentage Change of Average Monthly Volume had All Positives (100%) $LH #LH #LHStock #TickerDD #LHPrice https://www.youtube.com/watch?v=eILPjW2hC2k

Analyst Ratings
Argus Research Buy Mar 25, 24
Leerink Partners Outperform Feb 26, 24
Evercore ISI Group In-Line Feb 9, 24
Barclays Equal-Weight Jan 3, 24
JP Morgan Overweight Nov 17, 23
Mizuho Buy Oct 31, 23
B of A Securities Buy Sep 21, 23
Baird Outperform Sep 18, 23
Truist Securities Buy Sep 15, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wilkinson Peter J SVP, Chief Accountin.. SVP, Chief Accounting Officer Nov 16 Sell 210.713 1,384 291,627 2,087 11/20/23
ANDERSON KERRII B Director Director Aug 08 Sell 211.5665 5,000 1,057,832 15,275 08/10/23
Kirchgraber Paul R CEO, Covance Drug De.. CEO, Covance Drug Development May 19 Sell 216.91 4,300 932,713 12,946 05/23/23
Kirchgraber Paul R CEO, Covance Drug De.. CEO, Covance Drug Development May 19 Option 182.51 4,300 784,793 17,246 05/23/23
Schroeder Mark S EVP, President-Diagn.. EVP, President-Diagnostics Lab Mar 30 Sell 225.81 3,897 879,982 6,687 04/03/23
Kirchgraber Paul R CEO, Covance Drug De.. CEO, Covance Drug Development Feb 21 Sell 250.58 8,000 2,004,640 9,069 02/23/23
Kirchgraber Paul R CEO, Covance Drug De.. CEO, Covance Drug Development Feb 21 Option 182.51 3,000 547,530 17,069 02/23/23
Schroeder Mark S EVP, President-Diagn.. EVP, President-Diagnostics Lab Feb 14 Sell 247.63 309 76,518 6,687 02/16/23
van der Vaart Sandra D EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 07 Sell 243.01 219 53,219 5,341 02/09/23
Schroeder Mark S EVP, President-Diagn.. EVP, President-Diagnostics Lab Feb 07 Sell 243.01 409 99,391 6,687 02/09/23
Schroeder Mark S EVP, President-Diagn.. EVP, President-Diagnostics Lab Nov 08 Sell 232.67 1,116 259,660 6,687 11/10/22
EISENBERG GLENN A Chief Financial Offi.. Chief Financial Officer, EVP Sep 26 Sell 210.62 25,000 5,265,500 27,158 09/28/22
EISENBERG GLENN A Chief Financial Offi.. Chief Financial Officer, EVP Aug 03 Sell 254.13 32,100 8,157,573 52,158 08/05/22
EISENBERG GLENN A Chief Financial Offi.. Chief Financial Officer, EVP Aug 03 Option 148.56 32,100 4,768,776 84,258 08/05/22
Wilkinson Peter J SVP, Chief Accountin.. SVP, Chief Accounting Officer Aug 01 Sell 258.54 2,576 665,999 1,887 08/03/22
Wilkinson Peter J SVP, Chief Accountin.. SVP, Chief Accounting Officer Aug 01 Option 146.59 767 112,435 2,654 08/03/22
Caveney Brian J EVP, President of Di.. EVP, President of Diagnostics Jun 07 Buy 242.193 42 10,174 14,172 06/14/22
Schroeder Mark S EVP, President-Diagn.. EVP, President-Diagnostics Lab Mar 29 Sell 277.11 2,356 652,871 6,605 03/31/22
van der Vaart Sandra D EVP, Chief Legal Off.. EVP, Chief Legal Officer Mar 29 Sell 277.11 2,449 678,642 5,287 03/31/22
Williams R Sanders Director Director Mar 25 Sell 272.98 572 156,145 6,431 03/29/22
Summy Amy B. EVP, Chief Marketing.. EVP, Chief Marketing Officer Mar 10 Sell 262.21 249 65,290 250 03/14/22
NEUPERT PETER M Director Director Feb 16 Buy 263.8 3,500 923,300 10,254 02/18/22
Schroeder Mark S EVP, President-Diagn.. EVP, President-Diagnostics Lab Feb 15 Sell 273.98 207 56,714 6,605 02/17/22
van der Vaart Sandra D EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 15 Sell 273.98 207 56,714 5,287 02/17/22
Schroeder Mark S EVP, President-Diagn.. EVP, President-Diagnostics Lab Feb 04 Sell 277.38 204 56,586 6,605 02/08/22
van der Vaart Sandra D EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 04 Sell 277.38 218 60,469 5,287 02/08/22
Schroeder Mark S EVP, President-Diagn.. EVP, President-Diagnostics Lab Feb 02 Sell 271.81 161 43,761 6,401 02/04/22
van der Vaart Sandra D EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 02 Sell 271.81 172 46,751 5,287 02/04/22
van der Vaart Sandra D EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 17 Sell 296.78 4,500 1,335,510 5,265 09/17/21
van der Vaart Sandra D EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 17 Option 84.86 4,500 381,870 9,765 09/17/21
van der Vaart Sandra D EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 17 Sell 236.33 208 49,157 4,426 02/17/21